EN1 中文

Drug manufacturing

Drug production
Reaction capacity
Quality system certification Environment Health Safety (EHS) Environment and facilities Product catalog

Internal materials

  • Dual-phase steel
  • Glass lining
  • Stainless steel
  • Monel

Reaction conditions

  • 500~10000L
    Volume
  • -50℃~180℃
    Controllable temperature
  • 120units
    Equipment
  • 400m3
    Total capacity of equipment

Reaction types

  • 01
    Oxidation
  • 02
    Esterification
  • 03
    Hydrolysis reaction
  • 04
    Condensation
  • 05
    Friedel-Crafts acylation
  • 06
    Alkylation
  • 07
    Degradation
  • 08
    Substitution

Quality system certification

  • Product Name
    Indications
  • Ticagrelor
    Intended for patients with acute coronary syndrome (unstable angina, non-ST segment elevation myocardial infarction, or ST segment elevation myocardial infarction), including those receiving pharmacotherapy and percutaneous coronary intervention (PCI), to reduce the incidence of thrombotic cardiovascular events.
    Apply for CEP
    Submit DMF to FDA
    Pass ISO9001:2005 certification
    (For export only)
    Pass the inspection of APIs exported to EU
    Pass GMP (2010) compliance site inspection
  • Oxiracetam
    Used for the treatment of mild to moderate vascular dementia, Alzheimer's disease (senile dementia), brain trauma, and resulting neurological functional deficits, memory and intelligence disorders.
    Pass ISO9001:2005 certification
    Pass GMP (2010) compliance site inspection
  • L-carnitine
    For the prevention and treatment of L-carnitine deficiency, such as L-carnitine deficiency in patients with chronic renal failure due to hemodialysis; and for improving myocardial ischemia, treating angina and other clinical manifestations such as cardiomyopathy, skeletal myopathy (pain), arrhythmia, hyperlipidemia, as well as hypotension and myospasm in dialysis.
    Pass ISO9001:2005 certification
    (For export only) Apply for CEP
    Submit DMF to FDA
  • Ticagrelor intermediate
    ——
    Submit DMF to FDA
    Pass ISO9001:2005 certification

Environment Health Safety (EHS)

  • Environment

    Adequate sewage treatment facilities
    Efficient RTO exhaust treatment facilities

  • Health

    A sound occupational health management system
    Well-designed pre-job, in-job and off-job medical examinations

  • Safety

    Certified production safety standardization systems
    Effective identification, screening, and determination processes

Environment and facilities

  • Storage area
  • Dry workshop in non-clean area
  • Manufacturing workshop in non-clean area
  • Manufacturing workshop in clean area
  • Bipyramid
  • Purified water system
  • Class D clean area
  • Address

    Bldg. 12, No. 59 Kai Qing Rd, Pudong, Shanghai (West Campus)

    Bldg. 7, No. 509 Ren Qing Rd, Pudong, Shanghai (East Campus)

  • Investment Contact

    +86-21-50720228-202

  • Email

    sales@pharmaresources.cn

    Will reply as soon as possible.

Copyright © Copyright 2024 PharmaResources (Shanghai) Co., Ltd. (Official Website)---Privacy Policy

Reference No： Shanghai ICP 20013779 Website Constructed by：Ocean Design, Shanghai